DINATEQ
LIVE

Serial Number

79386306

Owner

DiNAQOR AG

Attorney

Alexander Montgomery

Filing Date

Aug 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DINATEQ Trademark

Serial Number: 79386306 • Registration: 7772611

DINATEQ is a trademark filed by DiNAQOR AG on August 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

DiNAQOR AG (4 trademarks)

Wagistrasse 25

Entity Type: 25

Trademark Details

Filing Date

August 4, 2023

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Development and programming of computer software and software platforms for others for use in medical, biomedical, veterinary and pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for data processing, storage and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; Stem cell research services; Consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research and development services relating to medical, biomedical, veterinary and pharmaceutical preparations; Providing information about medical, biomedical, veterinary and pharmaceutical scientific research and development; Biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; Scientific research and development with respect to the isolation and cultivation of human cells and tissues; Programming of computer software for others for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental of laboratory apparatus and instruments for scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching purposes for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development

Medical apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Surgical apparatus and instruments; Paramedical apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Veterinary apparatus and instruments for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases; Medical instruments for the fusion of medicines, namely, syringes, infusion pumps, syringe systems comprising syringes and medical tubing for administering drugs, intravenous mixing sets consisting of infusion bags sold empty, medical tubing for administering drugs, clamps for securing medical tubing, air filters, and luer connectors, medical laboratory mixers, medical vial reconstitution mixers, nebulizers, medicine autoinjectors sold empty, and balloon catheters; Apparatus for the regeneration of stem cells for medical purposes; Diagnostic apparatus for medical purposes, namely, for medical diagnostic testing related to heart and kidney diseases, except vascular and cardiovascular implants and implanted apparatus; Infusion sets; Artificial biomaterials for the argumentation of cardiac and kidney tissue for medical purposes

Pharmaceutical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; medicinal and biomedical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Biological tissue cultures for medical use; Biological solid organ tissue intended for subsequent implantation; Surgical implants made of living tissue; Biochemical preparations for medical use for the treatment of genetic diseases and cancers, heart diseases, liver diseases, kidney diseases, pancreas diseases, spleen diseases, lung diseases and cancer; Stem cells for medical use; pharmaceutical, medical, biomedical and veterinary preparations, in particular for the treatment of heart diseases

Recorded and downloadable computer software and platforms for data processing, storage and analysis for the development of gene therapies; recorded and downloadable computer software and computer software platforms for data processing, storage and analysis for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, measuring, signaling, detection, testing, inspection, and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical 2D scanners, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; weighing apparatus and instruments for use in medical, biomedical, veterinary and pharmaceutical research and development; Data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development

Providing medical information in the field of medical care as it relates to the preparation and dispensing medications, in particular for cardiomyopathy, heart failure and kidney diseases; Providing medical information and consulting services in the field of medical care as it relates to medical, biomedical, veterinary and pharmaceutical products; Genetic screening for medical, biomedical, veterinary and pharmaceutical purposes; Human heart and kidney tissue bank services; medical services relating to the removal, treatment and processing of stem cells

Advertising services; Commercial business administration, organization consulting, and management; Providing office functions; Business management consultancy; Company communication services, namely, public relations and providing business information for potential investors; Consulting services relating to personnel management; Personnel management; providing commercial information in the field of life science, health technology and medical technology; Providing marketing information; drawing up of statements of accounts; Retail store and wholesale store services featuring chemical and medical products and preparations, medical instruments and apparatus, and software in the medical field

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 15, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 15, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 29, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 12, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 20, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 20, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 20, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2024 TROA
REFUSAL PROCESSED BY IB
May 22, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 9, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 2, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 28, 2023 REPR